TechNavio today published its report Global Cancer Drug Market 2010“2014 based on an in-depth study focusing on the Americas, and the APAC and EMEA regions. The report aims to aid decision-makers™ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio™s Healthcare team said, Outsourcing of production is gaining pace in the pharmaceutical industry. The shift towards outsourcing of manufacturing is mostly done in view of cutting costs, getting quality service and reducing the time-to-market for new products into emerging pharmaceutical markets. The outsourcing of manufacturing is mostly done to China and India, as both the countries offer significant cost-reductions for drug R&D and manufacturing.
According to the report, globally, there has been an increase in the number of patients diagnosed with cancer as a result of the growing aging population and changing lifestyles. Certain types of infection and environmental exposure to different types of chemicals and radiation also result in cancer. This, in addition to other factors discussed in the report, has been driving the growth of this market.
The report also discusses the challenges faced by this market including alternative treatments for cancer such as surgery, radiation therapy, and biological therapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-cancer-drug-market-2010-2014
Follow us on Twitter @Technavio
TechNavio Announces the Publication of its Report – Global Cancer Drug Market 2010-2014
